Romofab Holding ApS: Financial statements 2022
CVR: 38556797
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Romofab Holding ApS (CVR 38556797) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -12,500 and a net result of DKK -28,986 compared with DKK -18,470 the year before. Equity in the 2022 report amounted to DKK 388,214. The solvency ratio was 19.4%.
- Gross Profit
- DKK -12,500
- Profit/Loss
- DKK -28,986
- Equity
- DKK 388,214
- Total Assets
- DKK 2,000,908
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -13 t. | -29 t. | 388 t. | 0 |
| 2021 | - | -16 t. | -18 t. | 417 t. | 0 |
| 2020 | - | -15 t. | -18 t. | 436 t. | 0 |
| 2019 | - | -15 t. | -18 t. | 454 t. | - |
| 2018 | - | -12 t. | -12 t. | 472 t. | - |
Official annual report
Keep an eye on Romofab Holding ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Romofab Holding ApS has published its annual report for 2021. Gross profit came to DKK -16,250, and the net result was DKK -18,470.
About Romofab Holding ApS
Romofab Holding ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Molly Bilde Fabrin and Robert Fabrin. The company is owned by Robert Fabrin and Molly Bilde Fabrin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -13,750 and a net result of DKK 284,766 compared with DKK -2,029,900 the year before. Equity in the 2025 report amounted to DKK -1,399,345.